Sign in

CIK 0001651308

  • Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981209416
Phone
+41 616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$48,487,541
in 9 filings, $47.8M under 10b5-1 plans

Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2016-02-08 Merck & Co., Inc. 10% owner Other acquisition +7,942,314 7,942,314
2016-02-08 Merck & Co., Inc. 10% owner Conversion · Series A Preferred Shares −18,518,519 0
2016-02-08 Merck & Co., Inc. 10% owner Conversion · Series A-2 Preferred Shares −5,128,205 0
2016-02-08 Hillhouse Capital Management, Ltd. 10% owner Conversion +30,626,779 30,626,779
2016-02-08 Hillhouse Capital Management, Ltd. 10% owner Purchase +9,100,000 39,726,779
2016-02-08 Hillhouse Capital Management, Ltd. 10% owner Conversion · Series A Preferred Shares +14,814,814 0
2016-02-08 Hillhouse Capital Management, Ltd. 10% owner Conversion · Series A-2 Preferred Shares +15,811,965 0
2016-02-08 BAKER BROS. ADVISORS LP Director Conversion +4,382,118 4,382,118
2016-02-08 BAKER BROS. ADVISORS LP Director Conversion +44,572,171 44,572,171
2016-02-08 BAKER BROS. ADVISORS LP Director Conversion +582,747 582,747
2016-02-08 BAKER BROS. ADVISORS LP Director Conversion +1,912,167 6,294,285
2016-02-08 BAKER BROS. ADVISORS LP Director Conversion +26,292,961 70,865,132
2016-02-08 BAKER BROS. ADVISORS LP Director Option exercise +238,850 $0.68 $161K 6,533,135
2016-02-08 BAKER BROS. ADVISORS LP Director Option exercise +2,296,890 $0.68 $1.6M 73,162,022
2016-02-08 BAKER BROS. ADVISORS LP Director Option exercise +56,853 $0.68 $38K 639,600
2016-02-08 BAKER BROS. ADVISORS LP Director Purchase +189,374 $24.00 $4.5M 189,374
2016-02-08 BAKER BROS. ADVISORS LP Director Purchase +1,723,306 $24.00 $41.4M 1,723,306
2016-02-08 BAKER BROS. ADVISORS LP Director Conversion · Series A Preferred shares −4,382,118 0
2016-02-08 BAKER BROS. ADVISORS LP Director Conversion · Series A Preferred shares −44,572,171 0
2016-02-08 BAKER BROS. ADVISORS LP Director Conversion · Series A Preferred shares −582,747 0

Page 122 of 123 · 2,455 trades